Abstract
This document presents the guidelines for anti-myelin-associated glycoprotein (MAG) antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of sponsoring Italian Association of Neuroimmunology (AINI) congresses. The main clinical information on anti-MAG antibody polyneuropathy, indications and limits of anti-MAG antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists. © 2017, Springer-Verlag Italia S.r.l.
Original language | English |
---|---|
Pages (from-to) | 249-252 |
Number of pages | 4 |
Journal | Neurological Sciences |
Volume | 38 |
Issue number | suppl 2 |
DOIs | |
Publication status | Published - 2017 |